Form 4 for KYNB KYNTRA BIO, INC.

Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-08 · accession 0001209191-23-018064 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-03-10	2023-03-08	KYNB	Conterno Enrique A	CEO, Dir	A - Grant	$0.00	+60.3K	379.2K	+19%	$0
M	2023-03-10	2023-03-08+	KYNB	Conterno Enrique A	CEO, Dir	S - Sale	$20.62	-56.3K	356.1K	-14%	-$1.16M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-03-08	A	A	37,229	$0.00	416,460	D	—	—	(F3) Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
2	Common	Common Stock	2023-03-10	S	D	12,103	$20.20	404,357	D	—	—	(F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
3	Common	Common Stock	2023-03-08	A	A	23,120	$0.00	379,231	D	—	—	(F2) Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
4	Common	Common Stock	2023-03-10	S	D	19,486	$20.20	384,868	D	—	—	(F4) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.
5	Common	Common Stock	2023-03-08	S	D	24,672	$21.16	356,111	D	—	—	(F1) Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.